Thus, the observed ectopic upregulation of JAK–STAT signaling in the TP53/RB1-deficient and SOX2-OE PCa cells raises the intriguing possibility that it may play a crucial role in acquiring lineage plasticity-driven AR therapy resistance. The gene discussed is TP53; the disease is posterior cortical atrophy.